The present invention relates to substantially pure metabolites of irara clomiphene. The invention is also directed to pharmaceutical compositions comprising these metabolites and their use in treating disorders including secondary hypogonadism type 2 diabetes elevated cholesterol elevated triglycerides wasting lipodystrophy female and male infertility benign prostate hypertrophy prostate cancer breast cancer ovarian cancer and endometrial cancer.
